IRBESARTAN MYLAN

150MG TBL NOB 28 I

SÚKL code 0235342
Name of the product IRBESARTAN MYLAN 150 MG
_MA_MEDICATION_DETAIL_INFO_MED_NAME i IRBESARTAN MYLAN
Supplement 150MG TBL NOB 28 I
Strenght 150MG
Pharmaceutical form Tablet
Package 28 I
Route Oral use
Language of the pack Czech
Wrap type Blister
Legal status na lékařský předpis
Active substance IRBESARTAN (IRBESARTANUM)
ATC group C09CA04
ATC group name IRBESARTAN

Marketing authorisation information

Registration Number 58/ 069/12-C
Type of MA A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state
MA status B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till)
Placed on the market till 31. 07. 2020
MA Holder Mylan Ireland Limited, Dublin
MA Holder country IRSKO
Actual MA holder Mylan Ireland Limited, Dublin
Actual MA holder country IRSKO

Back to list